Frederick Westhorpe

Judge
DISC Type : Dc

Chief Scientific Advisor at Biomia ApS

United Kingdom

Overview

Frederick is a leader in drug discovery at Brandaris Therapeutics, specializing in CNS therapeutics and biotech growth strategy. With a Ph. D. and postdoctoral training at Stanford, he excels at advancing small molecules into the clinic. Colleagues describe him as a knowledgeable, strategic, and thoughtful leader.

Outside the lab, Frederick shows a keen interest in the application of technology to life sciences. He has pursued certifications in data science and low-code data literacy platforms, indicating a passion for leveraging computational tools to drive research and innovation in his field.

He once led R&D for a platform capable of exploring previously inaccessible chemical space to generate novel therapeutics.

Personality Overview

Objective Thinker

Quality Focused

Features Driven

They put a lot of effort into ensuring personal success.  They are less concerned about the product and more about its potential impact. They like to stay in control of the negotiation or defining of the terms.

Topics They Care About

CNS Therapeutics
His current role at Brandaris Therapeutics focuses on developing non-hallucinogenic agonists for CNS indications like depression, building on his experience in neurodegeneration.
Biotech Startups
He has significant experience building and leading R&D strategy for early-stage companies, including CuraSen Therapeutics and Biomia ApS.
Drug Discovery
His career is dedicated to pushing the boundaries of science, from early discovery and preclinical research to designing clinical development strategies.

Media Appearances

Frederick has no verified media appearances

Work History

2-2026
Chief Scientific Advisor at Biomia ApS
11-2025
Head of Preclinical Research at Brandaris Therapeutics B.V.
5-2025 - 2-2026
Chief Scientific Officer at Biomia ApS
1-2025
Consultant - Biotech Growth, Portfolio Management and Preclinical Research Strategy at Freelance
12-2021 - 12-2024
Director - Discovery Pharmacology at COMPASS Pathways

Education

2012 - 2017
Postdoctoral Scholar from Stanford University School of Medicine
2007 - 2011
Doctor of Philosophy (Ph.D.) from The University of Manchester

More Information

Social Presence :

Prographics :

Exp : 18 Location : United Kingdom Job Level : Mid-senior Designation : Chief Scientific Advisor at Biomia ApS
URL has been copied!

Insights For Selling To Frederick

During A Call Or A Meeting

DO's

  • Help them weigh the risks by sharing objective proof points without becoming too analytical
  • When negotiating terms, help them build an impression that they are the ones calling the shots
  • Hold your ground without indulging in one-upmanship

DONT's

  • Don’t take too much time in sending them information if they ask for any
  • Don't try too hard to forge relationships with them
  • Do not hesitate from asking counter questions, just avoid challenging their authority

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Frederick is

  • Conviction around the impact matters the most to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Frederick

  • If they decide not to use your product, they will say no clearly.

Insights For Deal Planning

    How fast (or slow) will Frederick move?

  • If convinced, they can reach decisions quite fast.
  • Can Frederick take some risk or not?

  • They do not shy away from taking risks, but can be quite binary about them.

You And Frederick

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.